Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

3

Clinical Usefulness of ΔMELD to Predict the Survival of Patients with Liver Cirrhosis

Soo Hoon Eun, M.D., Yun Soo Kim, M.D. Jae Young Jang, M.D., Young Gook Cheon, M.D., Young Seok Kim, M.D., Young Deok Cho, M.D., Joon Sung Lee, M.D., Moon Sung Lee, M.D., Ju Hyun Kim, M.D. Chan Sup Shim, M.D., and Boo Sung Kim, M.D.

Clin Mol Hepatol. 2006;12(4):530-538. Published online January 1, 1970

View: 2748 Download: 20

Survival Analysis for Patients with Hepatocellular Carcinoma according to Stage, Liver Function and Treatment Modalities

Kyung Woo Park , Joong Won Park , Sang Hyung Cho , Young Il Kim , Seong Hoon Kim , Hong Suk Park , Woo Jin Lee , Sang Jae Park , Dae Young Kim , Eun Kyoung Hong , Chang

Clin Mol Hepatol. 2006;12(1):41-54. Published online January 1, 1970

View: 3073 Download: 21

Clinical Outcome of Pulmonary Resections in Patients with Pulmonary Metastasis of Hepatocellular Carcinoma

Kyung Kyu Kim, M.D., Ja Kyung Kim, M.D., Do Young Kim, M.D., Sang Hoon Ahn, M.D., Chae Yoon Chon, M.D., Young Myoung Moon, M.D., Kyung Young Chung, M.D. and Kwang-Hyub Han, M.D.

Clin Mol Hepatol. 2005;11(4):350-358. Published online January 1, 1970

View: 2911 Download: 20

The Incidence and Clinical Significance of Paraneoplastic Syndromes in Patients with Hepatocellular Carcinoma

Uh Young Huh, M.D., Jin Hyuk Kim, M.D., Byung-Ho Kim, M.D., Ki Deuk Nam, M.D., Jae Young Jang, M.D., Nam Hoon Kim, M.D., Sang Kil Lee, M.D., Kwang Ro Joo, M.D., Seok Ho Dong, M.D., Hyo Jong Kim, M.D., Young Woon Chang, M.D., Joung Il Lee, M.D., and Rin Chang, M.D.

Clin Mol Hepatol. 2005;11(3):275-283. Published online January 1, 1970

View: 3728 Download: 74

The Comparative Results of Radiofrequency Ablation versus Surgical Resection for the Treatment of Hepatocellular Carcinoma

Chang-Min Cho, M.D., Won-Young Tak, M.D., Young-Oh Kweon, M.D., Sung-Kook Kim, M.D., Yong-Hwan Choi, M.D., Yoon-Jin Hwang, M.D. and Yang-Il Kim, M.D.

Clin Mol Hepatol. 2005;11(1):59-71. Published online January 1, 1970

View: 3090 Download: 44

A Comparison of Patients With Hepatocellular Carcinoma Between A Short - term (Less Than 6 months) Survival Group and A Long - term (Over 24 Months) Survival Group After Treatment with Transcatheter Arterial Chemoembolization

In Koo Kang,Sung Woo Kim,Sung Hee Hahn,Seung Chul Cho,Chang Woo Cham,Dong Hoo Lee

Clin Mol Hepatol. 2002;8(2):189-200. Published online January 1, 2000

View: 2437 Download: 25

Prognostic Factors Affecting Survival Rate in Patients with Hepatocellular Carcinoma Treated by Transcatheter Chemoembolization

Sung Woo Kim,Soong hwan Lee,Byung Joo Roh,Jong Cheol Kim,Sung Soo Park,Dong Hoo Lee

Clin Mol Hepatol. 2000;6(3):311-320. Published online January 1, 2000

View: 2490 Download: 18

Survival and Prognostic Factors in Patients with Hepatocellular Carcinoma Who Showed Initial Good-Response to Transarterial Chemoembolization

Kyong Han Shin, Hyo Suk Lee, June Sung Lee, Gwang Hoon Woo, m Dong Kyung Chang, Jin Uk Jung*, Jae Hyung Park* and Chung Yong Kim

Clin Mol Hepatol. 1998;4(3):264-277. Published online January 1, 2000

View: 2181 Download: 13

Treatment outcome of the patients with small hepatoma ( ≤ 5 cm in diameter ) in relation to treatment modalities and underlying liver function

Kun Hoon Song , Kwang Hyub Han , Young Myung Moon , Chae Yoon Chon , Won Choi , Kwan Sik Lee , In Suh Park , Byong Ro Kim , Jong Tae Lee

Clin Mol Hepatol. 1996;2(2):186-197.

View: 65535 Download: 13

Original Article

Dynamic Assessment of Modified Quick Sequential Organ Failure Assessment in Acutely Deteriorated Patients with Chronic Liver Disease

Do Seon Song, Hee Yeon Kim, Young Kul Jung, Tae Hyung Kim, Hyung Joon Yim, Eileen L Yoon, Ki Tae Suk, Jeong-ju Yoo, Sang Gyune Kim, Moon Young Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Sung-Eun Kim, Jung-Hee Kim, Jung Gil Park, Won Kim, Jin Mo Yang, Dong Joon Kim, Ashok Kumar Choudhury, Vinod Arora, Shiv Kumar Sarin

Received December 27, 2023 Accepted April 9, 2024

DOI: https://doi.org/10.3350/cmh.2023.0563 [Accepted]

View: 206 Download: 15

1 | 2 |

Viewed By 5595	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4811	MAFLD: How is it different from NAFLD?
Viewed By 4553	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3718	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3706	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search